Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoporotic Fractures | 10 | 2022 | 415 | 2.070 |
Why?
|
Spinal Fractures | 9 | 2022 | 703 | 1.730 |
Why?
|
Gait | 11 | 2022 | 820 | 1.440 |
Why?
|
Movement | 8 | 2019 | 1462 | 1.310 |
Why?
|
Fractures, Compression | 4 | 2019 | 132 | 1.200 |
Why?
|
Geriatric Assessment | 5 | 2014 | 1429 | 1.040 |
Why?
|
Silver | 1 | 2024 | 120 | 0.890 |
Why?
|
Spinal Fusion | 10 | 2020 | 1302 | 0.870 |
Why?
|
Scoliosis | 8 | 2023 | 789 | 0.860 |
Why?
|
Fractures, Spontaneous | 1 | 2024 | 230 | 0.820 |
Why?
|
Muscle Strength | 4 | 2023 | 637 | 0.820 |
Why?
|
Teriparatide | 4 | 2022 | 225 | 0.820 |
Why?
|
Thoracic Vertebrae | 9 | 2022 | 614 | 0.790 |
Why?
|
Posture | 4 | 2014 | 954 | 0.790 |
Why?
|
Ankle | 2 | 2023 | 353 | 0.750 |
Why?
|
Alendronate | 2 | 2020 | 174 | 0.660 |
Why?
|
Spondylitis | 2 | 2021 | 20 | 0.610 |
Why?
|
Polysaccharides | 1 | 2024 | 1016 | 0.580 |
Why?
|
Skin Pigmentation | 1 | 2019 | 279 | 0.560 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2017 | 86 | 0.550 |
Why?
|
Bone Density Conservation Agents | 3 | 2022 | 791 | 0.550 |
Why?
|
Isometric Contraction | 3 | 2015 | 149 | 0.540 |
Why?
|
Fracture Healing | 2 | 2017 | 448 | 0.540 |
Why?
|
Dogs | 5 | 2011 | 3822 | 0.530 |
Why?
|
Bone Malalignment | 1 | 2016 | 38 | 0.530 |
Why?
|
Lumbar Vertebrae | 9 | 2022 | 1873 | 0.530 |
Why?
|
Palladium | 2 | 2014 | 67 | 0.520 |
Why?
|
Conjunctivitis | 1 | 2017 | 153 | 0.510 |
Why?
|
Antiviral Agents | 2 | 2024 | 3050 | 0.510 |
Why?
|
Dura Mater | 1 | 2017 | 296 | 0.490 |
Why?
|
Absorbable Implants | 1 | 2017 | 333 | 0.480 |
Why?
|
Doxycycline | 1 | 2017 | 349 | 0.480 |
Why?
|
Lysergic Acid | 2 | 2011 | 2 | 0.470 |
Why?
|
Kyphosis | 4 | 2021 | 251 | 0.470 |
Why?
|
Axons | 8 | 2010 | 1682 | 0.470 |
Why?
|
Arthroplasty, Replacement, Knee | 2 | 2022 | 1379 | 0.460 |
Why?
|
Cervical Vertebrae | 3 | 2021 | 974 | 0.430 |
Why?
|
Sex Characteristics | 1 | 2023 | 2643 | 0.420 |
Why?
|
Upper Extremity | 2 | 2019 | 682 | 0.410 |
Why?
|
Gonorrhea | 1 | 2017 | 354 | 0.410 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2011 | 633 | 0.410 |
Why?
|
Occipital Bone | 1 | 2012 | 55 | 0.400 |
Why?
|
Atlanto-Occipital Joint | 1 | 2012 | 32 | 0.400 |
Why?
|
Low Back Pain | 1 | 2020 | 987 | 0.380 |
Why?
|
Dietary Fats | 1 | 2019 | 2002 | 0.380 |
Why?
|
Pyramidal Tracts | 2 | 2010 | 249 | 0.380 |
Why?
|
Ethylene Oxide | 1 | 2011 | 28 | 0.370 |
Why?
|
Brain Injuries | 9 | 2010 | 2060 | 0.370 |
Why?
|
Thorax | 1 | 2014 | 554 | 0.360 |
Why?
|
Contingent Negative Variation | 1 | 2010 | 35 | 0.350 |
Why?
|
Activities of Daily Living | 4 | 2022 | 2415 | 0.350 |
Why?
|
Mycoses | 1 | 2013 | 389 | 0.330 |
Why?
|
Muscle, Skeletal | 5 | 2023 | 4958 | 0.300 |
Why?
|
Indoles | 2 | 2014 | 1839 | 0.300 |
Why?
|
H-Reflex | 2 | 2006 | 25 | 0.290 |
Why?
|
Gait Disorders, Neurologic | 1 | 2010 | 246 | 0.290 |
Why?
|
Organometallic Compounds | 1 | 2011 | 644 | 0.290 |
Why?
|
Aged, 80 and over | 21 | 2024 | 59489 | 0.290 |
Why?
|
Sodium Channels | 3 | 2009 | 334 | 0.290 |
Why?
|
Japan | 8 | 2020 | 1415 | 0.280 |
Why?
|
Spine | 4 | 2022 | 1128 | 0.280 |
Why?
|
Frail Elderly | 1 | 2012 | 785 | 0.280 |
Why?
|
Osteoporosis | 3 | 2022 | 1582 | 0.280 |
Why?
|
Zinc | 1 | 2011 | 675 | 0.270 |
Why?
|
Male | 61 | 2024 | 363698 | 0.270 |
Why?
|
Ganglia, Spinal | 3 | 2006 | 529 | 0.270 |
Why?
|
Neutropenia | 2 | 2011 | 893 | 0.270 |
Why?
|
Aged | 36 | 2024 | 171117 | 0.270 |
Why?
|
Walking | 2 | 2014 | 1198 | 0.260 |
Why?
|
Accidental Falls | 1 | 2014 | 1078 | 0.260 |
Why?
|
Arthroscopy | 1 | 2013 | 966 | 0.260 |
Why?
|
Tissue Survival | 1 | 2006 | 121 | 0.250 |
Why?
|
Muscular Diseases | 1 | 2010 | 550 | 0.250 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2228 | 0.240 |
Why?
|
Clusterin | 1 | 2005 | 71 | 0.240 |
Why?
|
Spinal Stenosis | 2 | 2018 | 257 | 0.240 |
Why?
|
Psychomotor Performance | 3 | 2010 | 1881 | 0.240 |
Why?
|
Decompression, Surgical | 3 | 2020 | 603 | 0.240 |
Why?
|
Time and Motion Studies | 2 | 2022 | 143 | 0.240 |
Why?
|
Microbial Sensitivity Tests | 2 | 2024 | 1971 | 0.230 |
Why?
|
Female | 58 | 2024 | 396112 | 0.230 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2004 | 27 | 0.230 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7478 | 0.230 |
Why?
|
Tetrodotoxin | 2 | 2009 | 244 | 0.230 |
Why?
|
Knee Joint | 4 | 2018 | 1656 | 0.230 |
Why?
|
Trauma, Nervous System | 1 | 2004 | 35 | 0.230 |
Why?
|
Staphylococcus epidermidis | 1 | 2024 | 121 | 0.230 |
Why?
|
Physical Therapy Modalities | 4 | 2019 | 533 | 0.220 |
Why?
|
Cell Transplantation | 1 | 2006 | 473 | 0.220 |
Why?
|
Sulfates | 1 | 2024 | 376 | 0.220 |
Why?
|
Arm | 1 | 2006 | 589 | 0.210 |
Why?
|
Interferons | 1 | 2007 | 714 | 0.210 |
Why?
|
Motor Cortex | 1 | 2010 | 1003 | 0.200 |
Why?
|
Apolipoproteins E | 2 | 2005 | 1458 | 0.200 |
Why?
|
Middle Aged | 32 | 2024 | 223009 | 0.200 |
Why?
|
Catalysis | 3 | 2014 | 770 | 0.200 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2022 | 17 | 0.200 |
Why?
|
Discitis | 1 | 2022 | 45 | 0.200 |
Why?
|
Ligamentum Flavum | 1 | 2022 | 20 | 0.200 |
Why?
|
Hepatitis C, Chronic | 2 | 2007 | 1032 | 0.190 |
Why?
|
Range of Motion, Articular | 4 | 2019 | 1594 | 0.190 |
Why?
|
Humans | 64 | 2024 | 765968 | 0.190 |
Why?
|
Diet | 1 | 2019 | 8086 | 0.190 |
Why?
|
Orthopedic Fixation Devices | 1 | 2021 | 76 | 0.190 |
Why?
|
Ankle Joint | 2 | 2023 | 450 | 0.180 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 608 | 0.180 |
Why?
|
Regeneration | 1 | 2010 | 1517 | 0.180 |
Why?
|
Sarcoma | 2 | 2023 | 1802 | 0.180 |
Why?
|
Femoral Fractures | 1 | 2024 | 375 | 0.180 |
Why?
|
Postural Balance | 2 | 2022 | 637 | 0.170 |
Why?
|
Liposarcoma | 1 | 2023 | 288 | 0.170 |
Why?
|
Postoperative Period | 2 | 2022 | 1816 | 0.170 |
Why?
|
Retrospective Studies | 22 | 2024 | 81514 | 0.170 |
Why?
|
Escherichia coli | 3 | 2024 | 4214 | 0.170 |
Why?
|
Xanthophylls | 1 | 2019 | 95 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2015 | 552 | 0.160 |
Why?
|
Mobility Limitation | 2 | 2014 | 408 | 0.160 |
Why?
|
Vertebroplasty | 1 | 2020 | 78 | 0.160 |
Why?
|
Rats | 15 | 2015 | 23707 | 0.160 |
Why?
|
Ossification, Heterotopic | 1 | 2022 | 239 | 0.160 |
Why?
|
Up-Regulation | 2 | 2005 | 4137 | 0.160 |
Why?
|
Tissue Engineering | 2 | 2006 | 1855 | 0.160 |
Why?
|
Biological Availability | 1 | 2019 | 385 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 10 | 2010 | 8102 | 0.150 |
Why?
|
Electromyography | 5 | 2015 | 1399 | 0.150 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2003 | 1116 | 0.150 |
Why?
|
Spinal Cord Injuries | 1 | 2006 | 927 | 0.150 |
Why?
|
Amyloid beta-Peptides | 4 | 2005 | 3896 | 0.150 |
Why?
|
Postoperative Complications | 6 | 2022 | 15747 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 1 | 2007 | 1175 | 0.140 |
Why?
|
Lower Extremity | 2 | 2016 | 1226 | 0.140 |
Why?
|
Prednisolone | 1 | 2018 | 324 | 0.140 |
Why?
|
Blood Loss, Surgical | 1 | 2021 | 629 | 0.140 |
Why?
|
Animals | 30 | 2024 | 168764 | 0.140 |
Why?
|
Anti-Infective Agents | 1 | 2024 | 986 | 0.140 |
Why?
|
Cyclization | 2 | 2014 | 60 | 0.140 |
Why?
|
Actinobacillus pleuropneumoniae | 1 | 2016 | 8 | 0.140 |
Why?
|
Zygapophyseal Joint | 1 | 2018 | 129 | 0.130 |
Why?
|
Spondylolisthesis | 1 | 2018 | 173 | 0.130 |
Why?
|
Oxidation-Reduction | 2 | 2014 | 2218 | 0.130 |
Why?
|
Carotenoids | 1 | 2019 | 619 | 0.130 |
Why?
|
Genome-Wide Association Study | 4 | 2023 | 12807 | 0.130 |
Why?
|
Ceftriaxone | 1 | 2017 | 176 | 0.130 |
Why?
|
Hemolysin Proteins | 1 | 2016 | 112 | 0.130 |
Why?
|
Osteosarcoma | 1 | 2022 | 909 | 0.130 |
Why?
|
Apoprotein(a) | 1 | 2015 | 17 | 0.130 |
Why?
|
Nuclear Transfer Techniques | 1 | 2015 | 61 | 0.120 |
Why?
|
Diphosphonates | 1 | 2020 | 625 | 0.120 |
Why?
|
Spinal Neoplasms | 1 | 2022 | 708 | 0.120 |
Why?
|
Connective Tissue Diseases | 1 | 2018 | 284 | 0.120 |
Why?
|
Swine | 5 | 2017 | 5988 | 0.120 |
Why?
|
Malus | 1 | 2015 | 50 | 0.120 |
Why?
|
Cerebral Cortex | 2 | 2010 | 5767 | 0.120 |
Why?
|
Sphingosine | 1 | 2017 | 306 | 0.120 |
Why?
|
Aging | 1 | 2014 | 8731 | 0.120 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 434 | 0.120 |
Why?
|
Electroencephalography | 1 | 2010 | 6273 | 0.120 |
Why?
|
Wound Infection | 1 | 2017 | 244 | 0.120 |
Why?
|
Ankle Brachial Index | 1 | 2015 | 166 | 0.120 |
Why?
|
Kyphoplasty | 1 | 2015 | 45 | 0.120 |
Why?
|
Neisseria gonorrhoeae | 1 | 2017 | 248 | 0.110 |
Why?
|
Parkinson Disease | 3 | 2019 | 2895 | 0.110 |
Why?
|
Neoplasms, Second Primary | 1 | 2022 | 1050 | 0.110 |
Why?
|
Hand | 1 | 2019 | 909 | 0.110 |
Why?
|
Eimeria | 1 | 2013 | 2 | 0.110 |
Why?
|
Coccidiostats | 1 | 2013 | 3 | 0.110 |
Why?
|
Coccidiosis | 1 | 2013 | 10 | 0.110 |
Why?
|
Poultry Diseases | 1 | 2013 | 24 | 0.110 |
Why?
|
Spiro Compounds | 1 | 2014 | 69 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2021 | 1171 | 0.110 |
Why?
|
Stereoisomerism | 2 | 2011 | 614 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2017 | 18293 | 0.110 |
Why?
|
Swine, Miniature | 1 | 2015 | 971 | 0.110 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2013 | 64 | 0.110 |
Why?
|
Stress, Mechanical | 4 | 2010 | 1668 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2108 | 0.100 |
Why?
|
Risk Factors | 7 | 2024 | 74840 | 0.100 |
Why?
|
Physical Endurance | 1 | 2015 | 368 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1165 | 0.100 |
Why?
|
Blotting, Western | 5 | 2009 | 5020 | 0.100 |
Why?
|
Erysipelas | 1 | 2012 | 3 | 0.100 |
Why?
|
Erysipelothrix | 1 | 2012 | 3 | 0.100 |
Why?
|
Nitrogen | 1 | 2014 | 346 | 0.100 |
Why?
|
Neurons | 6 | 2010 | 9525 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4908 | 0.100 |
Why?
|
Exercise Therapy | 1 | 2019 | 937 | 0.100 |
Why?
|
Swine Diseases | 1 | 2012 | 61 | 0.100 |
Why?
|
In Situ Hybridization | 3 | 2005 | 1886 | 0.100 |
Why?
|
Device Removal | 1 | 2017 | 646 | 0.100 |
Why?
|
Adult | 16 | 2023 | 223044 | 0.090 |
Why?
|
Leukocyte Count | 3 | 2011 | 1602 | 0.090 |
Why?
|
Spondylosis | 1 | 2012 | 84 | 0.090 |
Why?
|
Ergot Alkaloids | 1 | 2011 | 12 | 0.090 |
Why?
|
Chickens | 1 | 2013 | 842 | 0.090 |
Why?
|
Treatment Outcome | 11 | 2023 | 65188 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26318 | 0.090 |
Why?
|
Ergolines | 1 | 2011 | 55 | 0.090 |
Why?
|
Internal Fixators | 1 | 2012 | 183 | 0.090 |
Why?
|
Laminectomy | 1 | 2012 | 226 | 0.090 |
Why?
|
Hepatitis B, Chronic | 1 | 2015 | 412 | 0.090 |
Why?
|
Animals, Genetically Modified | 1 | 2015 | 1560 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2009 | 11022 | 0.090 |
Why?
|
Fingers | 2 | 2010 | 509 | 0.090 |
Why?
|
Advance Care Planning | 1 | 2018 | 702 | 0.090 |
Why?
|
Evoked Potentials, Motor | 2 | 2010 | 463 | 0.090 |
Why?
|
Molecular Conformation | 1 | 2011 | 541 | 0.080 |
Why?
|
Cerebral Palsy | 1 | 2014 | 481 | 0.080 |
Why?
|
Cell Culture Techniques | 3 | 2008 | 1652 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 1069 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2022 | 2567 | 0.080 |
Why?
|
Channelopathies | 1 | 2009 | 32 | 0.080 |
Why?
|
Adolescent | 13 | 2023 | 88835 | 0.080 |
Why?
|
Bone Plates | 1 | 2012 | 469 | 0.080 |
Why?
|
Genome, Bacterial | 1 | 2014 | 797 | 0.080 |
Why?
|
Dominance, Cerebral | 1 | 2010 | 616 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1660 | 0.080 |
Why?
|
Bone Screws | 1 | 2012 | 532 | 0.080 |
Why?
|
Rabbits | 3 | 2016 | 4734 | 0.080 |
Why?
|
Osteoarthritis, Knee | 1 | 2018 | 1248 | 0.070 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2014 | 1141 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4034 | 0.070 |
Why?
|
Sodium Channel Blockers | 2 | 2009 | 170 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2334 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 117 | 0.070 |
Why?
|
Dendrites | 1 | 2010 | 469 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4270 | 0.070 |
Why?
|
Muscular Atrophy | 1 | 2010 | 335 | 0.070 |
Why?
|
Reaction Time | 2 | 2010 | 2086 | 0.070 |
Why?
|
Radiography | 4 | 2018 | 6919 | 0.070 |
Why?
|
SEER Program | 2 | 2022 | 1446 | 0.070 |
Why?
|
Pain Measurement | 4 | 2019 | 3561 | 0.070 |
Why?
|
Young Adult | 7 | 2021 | 59889 | 0.070 |
Why?
|
Time Factors | 6 | 2021 | 40065 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2010 | 18973 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2010 | 1884 | 0.060 |
Why?
|
Spectrin | 1 | 2006 | 174 | 0.060 |
Why?
|
Cats | 2 | 2004 | 972 | 0.060 |
Why?
|
Risk Assessment | 2 | 2024 | 24282 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2007 | 525 | 0.060 |
Why?
|
Bacterial Proteins | 2 | 2016 | 3837 | 0.060 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2005 | 127 | 0.060 |
Why?
|
Dinucleoside Phosphates | 1 | 2004 | 71 | 0.060 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 2004 | 81 | 0.060 |
Why?
|
Ibuprofen | 1 | 2006 | 228 | 0.060 |
Why?
|
Cues | 2 | 2010 | 877 | 0.060 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2006 | 216 | 0.060 |
Why?
|
Autonomic Pathways | 1 | 2004 | 31 | 0.060 |
Why?
|
Choice Behavior | 1 | 2010 | 844 | 0.060 |
Why?
|
Magnesium Sulfate | 1 | 2004 | 74 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2005 | 513 | 0.060 |
Why?
|
Peripheral Arterial Disease | 1 | 2015 | 1311 | 0.050 |
Why?
|
Radioimmunoassay | 1 | 2004 | 860 | 0.050 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2010 | 1496 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2005 | 564 | 0.050 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2004 | 705 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3965 | 0.050 |
Why?
|
Optic Nerve | 1 | 2006 | 567 | 0.050 |
Why?
|
Trypsinogen | 1 | 2002 | 84 | 0.050 |
Why?
|
Guinea Pigs | 1 | 2004 | 1300 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2012 | 1759 | 0.050 |
Why?
|
Spinal Canal | 1 | 2022 | 42 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41649 | 0.050 |
Why?
|
Trypsin | 1 | 2002 | 487 | 0.050 |
Why?
|
Lung | 1 | 2020 | 10033 | 0.050 |
Why?
|
Motor Neurons | 1 | 2006 | 869 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 880 | 0.050 |
Why?
|
Bioprosthesis | 1 | 2005 | 589 | 0.050 |
Why?
|
Calcium | 4 | 2010 | 5767 | 0.050 |
Why?
|
Influenza Vaccines | 1 | 2008 | 778 | 0.050 |
Why?
|
Cerebral Ventricles | 1 | 2003 | 549 | 0.040 |
Why?
|
Endopeptidases | 1 | 2004 | 759 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5696 | 0.040 |
Why?
|
Fluorescent Dyes | 2 | 2009 | 1930 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2004 | 746 | 0.040 |
Why?
|
Biopsy | 2 | 2015 | 6763 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2022 | 346 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9071 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 2020 | 54 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14652 | 0.040 |
Why?
|
Hydrogels | 1 | 2006 | 728 | 0.040 |
Why?
|
Debridement | 1 | 2022 | 495 | 0.040 |
Why?
|
Glucocorticoids | 2 | 2020 | 2132 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15398 | 0.040 |
Why?
|
Nerve Regeneration | 1 | 2005 | 802 | 0.040 |
Why?
|
Body Mass Index | 3 | 2023 | 13039 | 0.040 |
Why?
|
Transcription Factors | 2 | 2022 | 12131 | 0.040 |
Why?
|
Attention | 1 | 2010 | 2419 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2003 | 485 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3424 | 0.040 |
Why?
|
Antibodies, Bacterial | 2 | 2016 | 1476 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4353 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39193 | 0.040 |
Why?
|
Abscess | 1 | 2022 | 606 | 0.040 |
Why?
|
Directed Tissue Donation | 1 | 2018 | 18 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2004 | 1857 | 0.040 |
Why?
|
Extremities | 1 | 2023 | 869 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2006 | 1682 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 1044 | 0.040 |
Why?
|
Neuroglia | 1 | 2003 | 964 | 0.040 |
Why?
|
Vital Capacity | 1 | 2020 | 995 | 0.040 |
Why?
|
RNA | 1 | 2007 | 2717 | 0.030 |
Why?
|
Actinobacillus Infections | 1 | 2016 | 17 | 0.030 |
Why?
|
Health Records, Personal | 1 | 2018 | 126 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2004 | 3160 | 0.030 |
Why?
|
Synapses | 1 | 2006 | 1754 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2021 | 592 | 0.030 |
Why?
|
DNA Primers | 2 | 2012 | 2825 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 1959 | 0.030 |
Why?
|
Skeletal Muscle Myosins | 1 | 2015 | 2 | 0.030 |
Why?
|
Advance Directives | 1 | 2018 | 251 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2005 | 12768 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2704 | 0.030 |
Why?
|
Pancreatitis | 1 | 2002 | 1087 | 0.030 |
Why?
|
Hippocampus | 2 | 2006 | 3775 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36532 | 0.030 |
Why?
|
Myoglobin | 1 | 2015 | 157 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2020 | 1828 | 0.030 |
Why?
|
Osteogenesis | 1 | 2022 | 1282 | 0.030 |
Why?
|
Antibodies | 1 | 2002 | 2417 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2015 | 822 | 0.030 |
Why?
|
Toes | 1 | 2015 | 209 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 2015 | 402 | 0.030 |
Why?
|
Gene Expression | 3 | 2016 | 7584 | 0.030 |
Why?
|
Maze Learning | 2 | 2006 | 482 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 16047 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 220 | 0.030 |
Why?
|
Uric Acid | 1 | 2019 | 809 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 198 | 0.030 |
Why?
|
Sigma Factor | 1 | 2014 | 178 | 0.030 |
Why?
|
Acriflavine | 1 | 2012 | 5 | 0.030 |
Why?
|
Genotype | 1 | 2007 | 13024 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2013 | 696 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2019 | 1820 | 0.020 |
Why?
|
Spinal Diseases | 1 | 2017 | 559 | 0.020 |
Why?
|
Immunization | 1 | 2016 | 1219 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2012 | 351 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2015 | 657 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3051 | 0.020 |
Why?
|
Serotyping | 1 | 2012 | 330 | 0.020 |
Why?
|
Embryo Transfer | 1 | 2015 | 525 | 0.020 |
Why?
|
Complementarity Determining Regions | 1 | 2012 | 154 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 3036 | 0.020 |
Why?
|
Back Pain | 1 | 2015 | 544 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2019 | 2140 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2554 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54802 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2015 | 1718 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2014 | 677 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2015 | 1735 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 805 | 0.020 |
Why?
|
Prognosis | 2 | 2023 | 29922 | 0.020 |
Why?
|
Dizocilpine Maleate | 1 | 2010 | 171 | 0.020 |
Why?
|
Xanthenes | 1 | 2009 | 71 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2003 | 3000 | 0.020 |
Why?
|
Child | 4 | 2020 | 80564 | 0.020 |
Why?
|
Reoperation | 1 | 2020 | 4294 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2014 | 1495 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2022 | 4209 | 0.020 |
Why?
|
Bone Density | 1 | 2022 | 3491 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 18071 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2008 | 36 | 0.020 |
Why?
|
Cognition | 1 | 2006 | 7049 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3946 | 0.020 |
Why?
|
Extracellular Space | 1 | 2010 | 563 | 0.020 |
Why?
|
Brain | 3 | 2004 | 27171 | 0.020 |
Why?
|
Dog Diseases | 1 | 2009 | 142 | 0.020 |
Why?
|
Virulence | 1 | 2012 | 1289 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3737 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5743 | 0.020 |
Why?
|
Species Specificity | 1 | 2012 | 2406 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7851 | 0.020 |
Why?
|
Independent Living | 1 | 2012 | 585 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2226 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12509 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2014 | 1308 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2014 | 1057 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9249 | 0.020 |
Why?
|
Equipment Design | 2 | 2005 | 3481 | 0.020 |
Why?
|
Astrocytes | 2 | 2006 | 1345 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2014 | 1402 | 0.020 |
Why?
|
Molecular Structure | 1 | 2011 | 1885 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6493 | 0.020 |
Why?
|
Antigens, Bacterial | 1 | 2012 | 1146 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 2084 | 0.020 |
Why?
|
Neocortex | 1 | 2010 | 414 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5379 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2267 | 0.020 |
Why?
|
Base Sequence | 2 | 2009 | 12403 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8067 | 0.020 |
Why?
|
Movement Disorders | 1 | 2010 | 461 | 0.020 |
Why?
|
Cell Enlargement | 1 | 2005 | 58 | 0.020 |
Why?
|
Cell Division | 2 | 2003 | 4475 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10603 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2006 | 380 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 896 | 0.010 |
Why?
|
Sodium | 1 | 2010 | 1591 | 0.010 |
Why?
|
Cell Line | 2 | 2009 | 15543 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13400 | 0.010 |
Why?
|
Aniline Compounds | 1 | 2009 | 1075 | 0.010 |
Why?
|
Growth Cones | 1 | 2004 | 117 | 0.010 |
Why?
|
Elasticity | 1 | 2005 | 652 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3681 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2018 | 20659 | 0.010 |
Why?
|
Neutrophils | 2 | 2009 | 3776 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21480 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2005 | 834 | 0.010 |
Why?
|
Interleukin-18 | 1 | 2004 | 251 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5786 | 0.010 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2004 | 309 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4622 | 0.010 |
Why?
|
Time | 1 | 2004 | 550 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2006 | 10729 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2004 | 579 | 0.010 |
Why?
|
Caspase 3 | 1 | 2004 | 731 | 0.010 |
Why?
|
Neurons, Afferent | 1 | 2004 | 497 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2006 | 748 | 0.010 |
Why?
|
Random Allocation | 1 | 2006 | 2395 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2004 | 1701 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13632 | 0.010 |
Why?
|
Viral Proteins | 1 | 2008 | 1797 | 0.010 |
Why?
|
Pilot Projects | 1 | 2014 | 8733 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2011 | 3672 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4772 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 2003 | 337 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2004 | 1162 | 0.010 |
Why?
|
Granulocytes | 1 | 2002 | 549 | 0.010 |
Why?
|
Mechanotransduction, Cellular | 1 | 2005 | 540 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10563 | 0.010 |
Why?
|
Virus Replication | 1 | 2008 | 2447 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20124 | 0.010 |
Why?
|
Cell Count | 1 | 2004 | 1823 | 0.010 |
Why?
|
Presenilin-1 | 1 | 2004 | 665 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5747 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1966 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2004 | 618 | 0.010 |
Why?
|
Kidney | 1 | 2015 | 7066 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2010 | 2686 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 13076 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9081 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15842 | 0.010 |
Why?
|
Macrophages | 2 | 2003 | 5772 | 0.010 |
Why?
|
Mutation | 1 | 2002 | 30198 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2006 | 6203 | 0.010 |
Why?
|
Microglia | 1 | 2006 | 1372 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2268 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 2627 | 0.010 |
Why?
|
Amyloidosis | 1 | 2003 | 885 | 0.010 |
Why?
|
United States | 1 | 2021 | 72903 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10429 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42500 | 0.010 |
Why?
|
Quality of Life | 1 | 2012 | 13462 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81819 | 0.000 |
Why?
|
Chronic Disease | 1 | 2002 | 9347 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11888 | 0.000 |
Why?
|
Age Factors | 1 | 2003 | 18380 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13648 | 0.000 |
Why?
|
Algorithms | 1 | 2006 | 14071 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 22340 | 0.000 |
Why?
|